276 related articles for article (PubMed ID: 35545767)
1. Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers.
Cai M; Zheng Z; Bai Z; Ouyang K; Wu Q; Xu S; Huang L; Jiang Y; Wang L; Gao J; Pathak JL; Wu L
BMC Cancer; 2022 May; 22(1):530. PubMed ID: 35545767
[TBL] [Abstract][Full Text] [Related]
2. MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell carcinomas.
Ahmed Haji Omar A; Haglund C; Virolainen S; Häyry V; Atula T; Kontio R; Salo T; Sorsa T; Hagström J
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Apr; 119(4):459-67. PubMed ID: 25697929
[TBL] [Abstract][Full Text] [Related]
3. MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.
Birkedal-Hansen B; Pavelic ZP; Gluckman JL; Stambrook P; Li YQ; Stetler-Stevenson WG
Oral Dis; 2000 Nov; 6(6):376-82. PubMed ID: 11355270
[TBL] [Abstract][Full Text] [Related]
4. Clinical validation of a saliva-based matrix metalloproteinase-1 rapid strip test for detection of oral cavity cancer.
Chu LJ; Chang YT; Chien CY; Chung HC; Wu SF; Chen CJ; Liu YC; Liao WC; Chen CH; Chiang WF; Chang KP; Wang JS; Yu JS
Biomed J; 2024 Feb; 47(1):100594. PubMed ID: 37044249
[TBL] [Abstract][Full Text] [Related]
5. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
[TBL] [Abstract][Full Text] [Related]
6. Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma.
Stott-Miller M; Houck JR; Lohavanichbutr P; Méndez E; Upton MP; Futran ND; Schwartz SM; Chen C
Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2628-36. PubMed ID: 21960692
[TBL] [Abstract][Full Text] [Related]
7. Association of Oral Cavity and Oropharyngeal Cancer Biomarkers in Surgical Drain Fluid With Patient Outcomes.
Lassig AAD; Joseph AM; Lindgren BR; Yueh B
JAMA Otolaryngol Head Neck Surg; 2017 Jul; 143(7):670-678. PubMed ID: 28418447
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic ability of salivary MMP-9 for oral squamous cell carcinoma: A pre-/post-surgery case and matched control study.
Shin YJ; Vu H; Lee JH; Kim HD
PLoS One; 2021; 16(3):e0248167. PubMed ID: 33735248
[TBL] [Abstract][Full Text] [Related]
9. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.
Ghallab NA; Shaker OG
Clin Oral Investig; 2017 Apr; 21(3):937-947. PubMed ID: 27161218
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinase-1, -9, -13, and tissue inhibitor of metalloproteinases-1 in basal cell carcinomas of the eyelid.
Zlatarova ZI; Softova EB; Dokova KG; Messmer EM
Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):425-31. PubMed ID: 21881840
[TBL] [Abstract][Full Text] [Related]
11. ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC).
Pramanik KK; Mishra R
Exp Cell Res; 2022 Feb; 411(1):112984. PubMed ID: 34951997
[TBL] [Abstract][Full Text] [Related]
12. Salivary MMPs, TIMPs, and MPO levels in periodontal disease patients and controls.
Meschiari CA; Marcaccini AM; Santos Moura BC; Zuardi LR; Tanus-Santos JE; Gerlach RF
Clin Chim Acta; 2013 Jun; 421():140-6. PubMed ID: 23501330
[TBL] [Abstract][Full Text] [Related]
13. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
Azevedo Martins JM; Rabelo-Santos SH; do Amaral Westin MC; Zeferino LC
BMC Cancer; 2020 Jul; 20(1):660. PubMed ID: 32669083
[TBL] [Abstract][Full Text] [Related]
14. Profile of Metalloproteinases and Their Association with Inflammatory Markers in Pleural Effusions.
Teixeira LR; Dias MB; Sales RK; Antonangelo L; Alvarenga VA; Puka J; Marchi E; Acencio MM
Lung; 2016 Dec; 194(6):1021-1027. PubMed ID: 27677622
[TBL] [Abstract][Full Text] [Related]
15. Probiotic intervention influences the salivary levels of Matrix Metalloproteinase (MMP)-9 and Tissue Inhibitor of metalloproteinases (TIMP)-1 in healthy adults.
Jäsberg H; Tervahartiala T; Sorsa T; Söderling E; Haukioja A
Arch Oral Biol; 2018 Jan; 85():58-63. PubMed ID: 29031239
[TBL] [Abstract][Full Text] [Related]
16. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
[TBL] [Abstract][Full Text] [Related]
17. May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer?
Shrestha B; Bajracharya D; Byatnal AA; Kamath A; Radhakrishnan R
Pathol Oncol Res; 2017 Jan; 23(1):197-206. PubMed ID: 27853937
[TBL] [Abstract][Full Text] [Related]
18. [Key enzymes of degradation and angiogenesis as a factors of tumor progression in squamous cell carcinoma of the cervix].
Solov'eva NI; Timoshenko OS; Kugaevskaia EV; Andreeva IuIu; Zavalishina LE
Bioorg Khim; 2014; 40(6):743-51. PubMed ID: 25895371
[TBL] [Abstract][Full Text] [Related]
19. Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma - a Systematic Review with Meta Analysis.
Hema Shree K; Ramani P; Sherlin H; Sukumaran G; Jeyaraj G; Don KR; Santhanam A; Ramasubramanian A; Sundar R
Pathol Oncol Res; 2019 Apr; 25(2):447-453. PubMed ID: 30712193
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
